Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

FRI0328 Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): 2-year data from tender, a phase 3 clinical trial

(2014) F. De Benedetti et al.   ANNALS OF THE RHEUMATIC DISEASES

Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis

(2012) Yoshinari Hattori et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases

(2012) Lisa Kaly et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition

(2012) Uta Kiltz et al.   CURRENT OPINION IN RHEUMATOLOGY

Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica

(2012) S. Unizony et al.   ARTHRITIS CARE & RESEARCH

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

(2011) David T. Felson et al.   ARTHRITIS AND RHEUMATISM

Biologic treatment of large-vessel vasculitides

(2011) Valentin S. Schäfer et al.   CURRENT OPINION IN RHEUMATOLOGY

Tocilizumab: a novel therapy for patients with large-vessel vasculitis

(2011) C. Salvarani et al.   RHEUMATOLOGY

Tocilizumab: A Novel Humanized Anti-Interleukin 6 Receptor Antibody for the Treatment of Patients with Rheumatoid Arthritis

(2011) Rieke Alten   Therapeutic Advances in Musculoskeletal Disease

Mixed response to tocilizumab for ankylosing spondylitis

(2010) J. C. Henes et al.   ANNALS OF THE RHEUMATIC DISEASES

Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

(2010) Gabor G. Illei et al.   ARTHRITIS AND RHEUMATISM

The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis

(2010) William P. Arend et al.   ARTHRITIS AND RHEUMATISM

Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis

(2010) Daichi Inoue et al.   CLINICAL RHEUMATOLOGY

Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists

(2010) Laure Brulhart et al.   JOINT BONE SPINE

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

(2010) Shigeru Kotake et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis

(2010) Nicolas Frey et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica

(2010) K. HAGIHARA et al.   JOURNAL OF RHEUMATOLOGY

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab

(2010) Y. Shima et al.   RHEUMATOLOGY

Tocilizumab in refractory adult Still's disease

(2010) Xavier Puéchal et al.   ARTHRITIS CARE & RESEARCH

Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment

(2009) S Nishida et al.   ANNALS OF THE RHEUMATIC DISEASES

Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis

(2009) Hiroe Sato et al.   CLINICAL RHEUMATOLOGY

Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab

(2009) T. Tanaka et al.   RHEUMATOLOGY

Successful treatment of a patient with takayasu arteritis using a humanized anti-interleukin-6 receptor antibody

(2008) Norihiro Nishimoto et al.   ARTHRITIS AND RHEUMATISM

Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis

(2008) M. Kawai et al.   RHEUMATOLOGY